Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity

I. Hsun Li, Kuo Hsing Ma, Tzu Jen Kao, Yang Yi Lin, Shao Ju Weng, Ting Yin Yen, Lih Chi Chen, Yuahn Sieh Huang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

It has been suggested that autophagy plays pathogenetic roles in cerebral ischemia, brain trauma, and neurodegenerative disorders. 3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is an illicit drug that causes long-term serotonergic neurotoxicity in the brain. Apoptosis and necrosis have been implicated in MDMA-induced neurotoxicity, but the role of autophagy in MDMA-elicited serotonergic toxicity has not been investigated. The present study aimed to examine the contribution of autophagy to neurotoxicity in serotonergic neurons in in vitro and in vivo animal models challenged with MDMA. Here, we demonstrated that in cultured rat serotonergic neurons, MDMA exposure induced LC3B-densely stained autophagosome formation, accompanying by a decrease in neurite outgrowth. Autophagy inhibitor 3-methyladenine (3-MA) significantly attenuated MDMA-induced autophagosome accumulation, and ameliorated MDMA-triggered serotonergic neurite damage and neuron death. In contrast, enhanced autophagy flux by rapamycin or impaired autophagosome clearance by bafilomycin A1 led to more autophagosome accumulation in serotonergic neurons and aggravated neurite degeneration. In addition, MDMA-induced autophagy activation in cultured serotonergic neurons might be mediated by serotonin transporter (SERT). In an in vivo animal model administered MDMA, neuroimaging showed that 3-MA protected the serotonin system against MDMA-induced downregulation of SERT evaluated by animal-PET with 4-[18F]-ADAM, a SERT radioligand. Taken together, our results demonstrated that MDMA triggers upregulation of autophagy in serotonergic neurons, which appears to be detrimental to neuronal growth.

Original languageEnglish
Pages (from-to)114-126
Number of pages13
JournalNeuroToxicology
Volume52
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Autophagy
Up-Regulation
Serotonergic Neurons
Neurons
Serotonin Plasma Membrane Transport Proteins
Animals
Neurites
Brain
Animal Models
Neuroimaging
Brain Diseases
Street Drugs
Sirolimus
Brain Ischemia
Neurodegenerative Diseases
Toxicity
Rats
Serotonin
Necrosis

Keywords

  • 3-Methyladenine
  • Autophagy
  • LC3B
  • MDMA
  • Serotonergic neuron
  • Tryptophan hydroxylase

ASJC Scopus subject areas

  • Neuroscience(all)
  • Toxicology

Cite this

Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity. / Li, I. Hsun; Ma, Kuo Hsing; Kao, Tzu Jen; Lin, Yang Yi; Weng, Shao Ju; Yen, Ting Yin; Chen, Lih Chi; Huang, Yuahn Sieh.

In: NeuroToxicology, Vol. 52, 01.01.2016, p. 114-126.

Research output: Contribution to journalArticle

Li, I. Hsun ; Ma, Kuo Hsing ; Kao, Tzu Jen ; Lin, Yang Yi ; Weng, Shao Ju ; Yen, Ting Yin ; Chen, Lih Chi ; Huang, Yuahn Sieh. / Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity. In: NeuroToxicology. 2016 ; Vol. 52. pp. 114-126.
@article{14ad513f347e455c809d59898c3cfe04,
title = "Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity",
abstract = "It has been suggested that autophagy plays pathogenetic roles in cerebral ischemia, brain trauma, and neurodegenerative disorders. 3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is an illicit drug that causes long-term serotonergic neurotoxicity in the brain. Apoptosis and necrosis have been implicated in MDMA-induced neurotoxicity, but the role of autophagy in MDMA-elicited serotonergic toxicity has not been investigated. The present study aimed to examine the contribution of autophagy to neurotoxicity in serotonergic neurons in in vitro and in vivo animal models challenged with MDMA. Here, we demonstrated that in cultured rat serotonergic neurons, MDMA exposure induced LC3B-densely stained autophagosome formation, accompanying by a decrease in neurite outgrowth. Autophagy inhibitor 3-methyladenine (3-MA) significantly attenuated MDMA-induced autophagosome accumulation, and ameliorated MDMA-triggered serotonergic neurite damage and neuron death. In contrast, enhanced autophagy flux by rapamycin or impaired autophagosome clearance by bafilomycin A1 led to more autophagosome accumulation in serotonergic neurons and aggravated neurite degeneration. In addition, MDMA-induced autophagy activation in cultured serotonergic neurons might be mediated by serotonin transporter (SERT). In an in vivo animal model administered MDMA, neuroimaging showed that 3-MA protected the serotonin system against MDMA-induced downregulation of SERT evaluated by animal-PET with 4-[18F]-ADAM, a SERT radioligand. Taken together, our results demonstrated that MDMA triggers upregulation of autophagy in serotonergic neurons, which appears to be detrimental to neuronal growth.",
keywords = "3-Methyladenine, Autophagy, LC3B, MDMA, Serotonergic neuron, Tryptophan hydroxylase",
author = "Li, {I. Hsun} and Ma, {Kuo Hsing} and Kao, {Tzu Jen} and Lin, {Yang Yi} and Weng, {Shao Ju} and Yen, {Ting Yin} and Chen, {Lih Chi} and Huang, {Yuahn Sieh}",
year = "2016",
month = "1",
day = "1",
doi = "10.1016/j.neuro.2015.11.009",
language = "English",
volume = "52",
pages = "114--126",
journal = "NeuroToxicology",
issn = "0161-813X",
publisher = "Elsevier",

}

TY - JOUR

T1 - Involvement of autophagy upregulation in 3,4-methylenedioxymethamphetamine ('ecstasy')-induced serotonergic neurotoxicity

AU - Li, I. Hsun

AU - Ma, Kuo Hsing

AU - Kao, Tzu Jen

AU - Lin, Yang Yi

AU - Weng, Shao Ju

AU - Yen, Ting Yin

AU - Chen, Lih Chi

AU - Huang, Yuahn Sieh

PY - 2016/1/1

Y1 - 2016/1/1

N2 - It has been suggested that autophagy plays pathogenetic roles in cerebral ischemia, brain trauma, and neurodegenerative disorders. 3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is an illicit drug that causes long-term serotonergic neurotoxicity in the brain. Apoptosis and necrosis have been implicated in MDMA-induced neurotoxicity, but the role of autophagy in MDMA-elicited serotonergic toxicity has not been investigated. The present study aimed to examine the contribution of autophagy to neurotoxicity in serotonergic neurons in in vitro and in vivo animal models challenged with MDMA. Here, we demonstrated that in cultured rat serotonergic neurons, MDMA exposure induced LC3B-densely stained autophagosome formation, accompanying by a decrease in neurite outgrowth. Autophagy inhibitor 3-methyladenine (3-MA) significantly attenuated MDMA-induced autophagosome accumulation, and ameliorated MDMA-triggered serotonergic neurite damage and neuron death. In contrast, enhanced autophagy flux by rapamycin or impaired autophagosome clearance by bafilomycin A1 led to more autophagosome accumulation in serotonergic neurons and aggravated neurite degeneration. In addition, MDMA-induced autophagy activation in cultured serotonergic neurons might be mediated by serotonin transporter (SERT). In an in vivo animal model administered MDMA, neuroimaging showed that 3-MA protected the serotonin system against MDMA-induced downregulation of SERT evaluated by animal-PET with 4-[18F]-ADAM, a SERT radioligand. Taken together, our results demonstrated that MDMA triggers upregulation of autophagy in serotonergic neurons, which appears to be detrimental to neuronal growth.

AB - It has been suggested that autophagy plays pathogenetic roles in cerebral ischemia, brain trauma, and neurodegenerative disorders. 3,4-Methylenedioxymethamphetamine (MDMA or ecstasy) is an illicit drug that causes long-term serotonergic neurotoxicity in the brain. Apoptosis and necrosis have been implicated in MDMA-induced neurotoxicity, but the role of autophagy in MDMA-elicited serotonergic toxicity has not been investigated. The present study aimed to examine the contribution of autophagy to neurotoxicity in serotonergic neurons in in vitro and in vivo animal models challenged with MDMA. Here, we demonstrated that in cultured rat serotonergic neurons, MDMA exposure induced LC3B-densely stained autophagosome formation, accompanying by a decrease in neurite outgrowth. Autophagy inhibitor 3-methyladenine (3-MA) significantly attenuated MDMA-induced autophagosome accumulation, and ameliorated MDMA-triggered serotonergic neurite damage and neuron death. In contrast, enhanced autophagy flux by rapamycin or impaired autophagosome clearance by bafilomycin A1 led to more autophagosome accumulation in serotonergic neurons and aggravated neurite degeneration. In addition, MDMA-induced autophagy activation in cultured serotonergic neurons might be mediated by serotonin transporter (SERT). In an in vivo animal model administered MDMA, neuroimaging showed that 3-MA protected the serotonin system against MDMA-induced downregulation of SERT evaluated by animal-PET with 4-[18F]-ADAM, a SERT radioligand. Taken together, our results demonstrated that MDMA triggers upregulation of autophagy in serotonergic neurons, which appears to be detrimental to neuronal growth.

KW - 3-Methyladenine

KW - Autophagy

KW - LC3B

KW - MDMA

KW - Serotonergic neuron

KW - Tryptophan hydroxylase

UR - http://www.scopus.com/inward/record.url?scp=84949293325&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949293325&partnerID=8YFLogxK

U2 - 10.1016/j.neuro.2015.11.009

DO - 10.1016/j.neuro.2015.11.009

M3 - Article

C2 - 26610922

AN - SCOPUS:84949293325

VL - 52

SP - 114

EP - 126

JO - NeuroToxicology

JF - NeuroToxicology

SN - 0161-813X

ER -